Literature DB >> 15019931

Effects of manometrically discovered nonspecific motility disorders of the esophagus on the outcomes of antireflux surgery.

Vic Velanovich1, Arvind Mahatme.   

Abstract

Nonspecific motility disorders (NMDs) of the esophagus are common manometric findings in patients evaluated for gastroesophageal reflux disease (GERD). However, it is unclear how these disorders affect the outcomes of antireflux surgery. The purpose of this study was to assess symptomatic outcomes of patients with and without NMDs undergoing surgical treatment for GERD. A prospectively gathered database of all patients undergoing antireflux surgery was retrospectively reviewed for preoperative symptoms, symptom severity using the GERD-HRQL (best score 0, worst score 50), esophageal manometry measurements, presence of NMD, type of operation, any transient or permanent postoperative dysphagia, severity of postoperative dysphagia (best score 0, worst score 5), and postoperative symptom severity. A total of 239 patients were studied; 24% had a NMD identified by preoperative esophageal manometry, and 17% of this +NMD group had preoperative dysphagia or atypical chest/epigastric pain compared to 28% of those without a NMD (-NMD group) (P=NS). Preoperative symptom scores were +NMD 33 vs. -NMD 27 (P=0.01). Postoperative symptom scores were +NMD 5 vs. -NMD 3 (P=NS). There were no differences in preoperative or postoperative dysphagia scores. Transient postoperative dysphagia was 15.8% in the +NMD group vs. 16.4% in the -NMD group (P=NS). Postoperative dilation was 0% in the +NMD group vs. 2% in the -NMD group (P=NS). Manometrically discovered NMDs do not appear to affect preoperative symptoms or symptomatic outcomes of patients surgically treated for GERD. These findings my reflect the severity of GERD and may improve with antireflux surgery.

Entities:  

Mesh:

Year:  2004        PMID: 15019931     DOI: 10.1016/j.gassur.2003.10.010

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  23 in total

1.  Functional chest pain of esophageal origin: hyperalgesia or motor dysfunction.

Authors:  S S Rao; B Hayek; R W Summers
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

2.  Role of esophageal body function in gastroesophageal reflux disease: implications for surgical management.

Authors:  S Rakic; H J Stein; T R DeMeester; R N Hinder
Journal:  J Am Coll Surg       Date:  1997-10       Impact factor: 6.113

3.  Tailored augmentation of the lower esophageal sphincter in experimental antireflux operations.

Authors:  S M Freys; K H Fuchs; J Heimbucher; A Thiede
Journal:  Surg Endosc       Date:  1997-12       Impact factor: 4.584

4.  Predictability of dysphagia after laparoscopic nissen fundoplication.

Authors:  T Kamolz; T Bammer; R Pointner
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

5.  Tailored antireflux surgery for gastroesophageal reflux disease: effectiveness and risk of postoperative dysphagia.

Authors:  G J Wetscher; K Glaser; T Wieschemeyer; M Gadenstaetter; R Prommegger; C Profanter
Journal:  World J Surg       Date:  1997 Jul-Aug       Impact factor: 3.352

6.  Dysphagia after laparoscopic antireflux surgery. The impact of operative technique.

Authors:  J G Hunter; L Swanstrom; J P Waring
Journal:  Ann Surg       Date:  1996-07       Impact factor: 12.969

7.  Oesophageal motor and sensitivity abnormalities in non-obstructive dysphagia.

Authors:  Benoit Bohn; Bruno Bonaz; Nasser Gueddah; Alain Rolachon; Emmanuel Papillon; Richard Bost; Jacques Fournet
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-03       Impact factor: 2.566

8.  Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder.

Authors:  L P Leite; B T Johnston; J Barrett; J A Castell; D O Castell
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

9.  Complete fundoplication has similar long-term results in patients with and without esophageal body dysmotility.

Authors:  B Goss; Y Shacham; A Szold
Journal:  Surg Endosc       Date:  2003-02-10       Impact factor: 4.584

10.  Quality of life for patients with gastroesophageal reflux disease 2 years after laparoscopic fundoplication. Evaluation of the results obtained during the initial experience.

Authors:  S Contini; A Bertelé; G Nervi; R Zinicola; C Scarpignato
Journal:  Surg Endosc       Date:  2002-06-20       Impact factor: 4.584

View more
  5 in total

1.  Influence of age on outcome of total laparoscopic fundoplication for gastroesophageal reflux disease.

Authors:  F Pizza; G Rossetti; P Limongelli; G Del Genio; V Maffettone; V Napolitano; L Brusciano; G Russo; S Tolone; M Di Martino; A Del Genio
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

2.  Clinical outcomes of atypical extra-esophageal reflux symptoms following laparoscopic antireflux surgery.

Authors:  Shaun R Brown; C Prakash Gyawali; Lora Melman; Eric D Jenkins; Julia Bader; Margaret M Frisella; L Michael Brunt; J Christopher Eagon; Brent D Matthews
Journal:  Surg Endosc       Date:  2011-06-30       Impact factor: 4.584

3.  The use of esophageal transit and gastric emptying studies in the evaluation of patients undergoing laparoscopic fundoplication.

Authors:  Matthew J Schuchert; Brian L Pettiford; Ghulam Abbas; Alicia Oostdyk; James R Landreneau; Arman Kilic; Joshua P Landreneau; James D Luketich; Rodney J Landreneau
Journal:  Surg Endosc       Date:  2010-05-19       Impact factor: 4.584

Review 4.  Gastrointestinal complications of fundoplication.

Authors:  Frances Connor
Journal:  Curr Gastroenterol Rep       Date:  2005-06

5.  Is the advanced age a contraindication to GERD laparoscopic surgery? Results of a long term follow-up.

Authors:  Landino Fei; Gianluca Rossetti; Francesco Moccia; Teresa Marra; Paolo Guadagno; Ludovico Docimo; Marco Cimmino; Vincenzo Napolitano; Giovanni Docimo; Domenico Napoletano; Ludovica Guerriero; Beniamino Pascotto
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.